Connacht Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,561
Closed -$397K 121
2023
Q1
$397K Sell
2,561
-3,468
-58% -$560K 0.17% 90
2022
Q4
$1.07M Sell
6,029
-928
-13% -$160K 0.48% 45
2022
Q3
$1.14M Sell
6,957
-2,225
-24% -$377K 0.81% 35
2022
Q2
$1.63M Buy
+9,182
New +$1.64M 0.68% 34

Other funds holding JNJ

Connacht Asset Management's JNJ Position: Q2 2023 in Review

Connacht Asset Management sold out of Johnson & Johnson (JNJ) in Q2 2023, closing a stake of 2,561 shares — an estimated $397K sold.

Connacht Asset Management first reported a position in JNJ in Q2 2022 and held it in 4 quarters. The position peaked at $1.63M in Q2 2022. 3,753 funds tracked by Wall St. Rank hold JNJ as of Q2 2023.

  • Connacht Asset Management reported no remaining Johnson & Johnson position as of Q2 2023 after selling out during the quarter.
  • Connacht Asset Management sold 2,561 Johnson & Johnson shares in Q2 2023, an estimated $397K.
  • Connacht Asset Management first reported a position in Johnson & Johnson in Q2 2022 and held it in 4 quarters.
  • Connacht Asset Management's Johnson & Johnson position peaked at $1.63M in Q2 2022.
  • 3,753 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2023.

Based on Connacht Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.